Last updated on February 2018

The Mechanism of Modified Utral-long Protocol in Improving Endometrial Receptivity in Patients With PCOS and IR


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Polycystic Ovary Syndrome
  • Age: Between 20 - 35 Years
  • Gender: Female

Inclusion Criteria:

  • age36years,
  • PCOS,
  • Insulin resistance (HOMA-IR = fasting insulin (FINS) fasting blood glucose (FPG) / 22.5, HOMA-IR 2.69 ;

Exclusion Criteria:

  • uterine abnormalities (double uterus, bicornuate uterus, unicornuate uterus and uterine mediastinum),
  • intrauterine adhesions,
  • endometriosis, adenomyosis,
  • Hydrosalpinx,
  • uterine fibroids (submucosal fibroids, non-mucosal fibroids > 4 cm and / or endometrial pressure),
  • Hyroid dysfunction and hyperprolactinemia.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.